Last update 24 May 2025

NKL-001

Overview

Basic Info

Drug Type
CIR-NK
Synonyms
Anti-HLA-G(NKILT), NKL 001, NKL001
Target
HLA-G
Action
inhibitors
Mechanism
HLA-G inhibitors(major histocompatibility complex, class I, G inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Multiple MyelomaAcute Myeloid Leukemia
Inactive Indication-
Originator Organization
NKILT Therapeutics, Inc.NKILT Therapeutics, Inc.
Active Organization
NKILT Therapeutics, Inc.NKILT Therapeutics, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with NKL-001
Login to view more data
100 Translational Medicine associated with NKL-001
Login to view more data
100 Patents (Medical) associated with NKL-001
Login to view more data
1
Literatures (Medical) associated with NKL-001
01 Oct 2020Cancer discoveryQ1 · MEDICINE
Gilead Buys into Tizona's Anti–HLA-G Strategy
Q1 · MEDICINE
100 Deals associated with NKL-001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple MyelomaPreclinical
United States
NKILT Therapeutics, Inc.NKILT Therapeutics, Inc.
28 Apr 2025
Acute Myeloid LeukemiaPreclinical
United States
NKILT Therapeutics, Inc.NKILT Therapeutics, Inc.
03 Nov 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free